By Miss Georgia Jane McCaughan

Journal articles

Hoff FW; Banerjee R; Khan AM; McCaughan G; Wang B; Wang X; Roose J; Anderson LD; Cowan AJ; Rajkumar SV; Kaur G, 2024, 'Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis', Blood Cancer Journal, 14, http://dx.doi.org/10.1038/s41408-024-01034-6

Banerjee R; Wang B; Anderson LD; McCaughan G; Mehra N; Cowan AJ; Rajkumar SV; Kaur G, 2023, 'Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians', Blood Cancer Journal, 13, http://dx.doi.org/10.1038/s41408-023-00937-0

Lasica M; Spencer A; Horvath N; Janowski W; Coghlan D; Wallington-Gates C; Campbell P; Lai HC; McCaughan G; Weber N; Puliyayil A; Wong P; Yachao D; Le K; Reynolds J; Quach H, 2023, 'A Phase I/II Single Arm Study of Belantamab Mafodotin, Carfilzomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: Planned Interim Analysis of Safety and Efficacy. Amarc 19-02 Belacard Study', Blood, 142, pp. 2012 - 2012, http://dx.doi.org/10.1182/blood-2023-189005

Rajasekariah H; McCaughan G; Ma CKK; Gorrie N; Milliken S; Ma D; Fay K; Withers B; Hamad N; Birch S; Keogh A; Jabbour A; Hayward C; Macdonald P; Moore J, 2023, 'Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study', Blood, 142, pp. 3414 - 3414, http://dx.doi.org/10.1182/blood-2023-184319

Quach H; Lasica M; Low M; Mollee P; Lai HC; Wong Doo N; Hocking J; Campbell P; Murphy NE; Sidiqi MH; Routledge D; Heenan J; Horvath N; Eek R; Renwick WEP; Lenton DS; Child LJ; McCaughan G; Butcher BE; Mazumdar D; Kalff A, 2023, 'Planned Interim Safety Analysis of the Phase 3 Randomized Trial of Selinexor and Lenalidomide Versus Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Patients with Newly Diagnosed Multiple Myeloma (ALLG MM23; Sealand)', Blood, 142, pp. 2023 - 2023, http://dx.doi.org/10.1182/blood-2023-185169

Hoff FW; Banerjee R; Khan A; McCaughan G; Wang XW; Roose J; Anderson LD; Cowan AJ; Rajkumar V; Kaur G, 2023, 'Retrospective Observational Study on Real-World Bortezomib Prescribing Patterns and Outcomes in Newly Diagnosed Multiple Myeloma', Blood, 142, pp. 544 - 544, http://dx.doi.org/10.1182/blood-2023-178950

Banerjee R; Kaur G; Wang B; Anderson LD; McCaughan G; Cowan AJ; Rajkumar SV, 2023, 'Standard-of-Care Bortezomib Dosing in Multiple Myeloma: An International Survey of Physicians', Blood, 142, pp. 5073 - 5073, http://dx.doi.org/10.1182/blood-2023-173772

Moore E; Harrison S; Ho PJ; Irving A; King T; Mccaughan G; Mcquilten Z; Mollee P; Park S; Petrie D; Reynolds J; Rutherford C; van Tonder T; Wellard C; Wood E; Spencer A, 2023, 'PB2698: MORE EFFICIENT DELIVERY OF HIGH-COST STANDARD-OF-CARE THERAPIES IN RELAPSED MULTIPLE MYELOMA USING REAL-TIME FEEDBACK OF PATIENT-REPORTED OUTCOME MEASURES: THE MY-PROMPT-2 TRIAL', HemaSphere, 7, pp. e68933f0 - e68933f0, http://dx.doi.org/10.1097/01.hs9.0000977464.68933.f0

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Withers B; Hamad N, 2023, 'Rates of Menstrual History-Taking and Counseling With Anticancer Treatments Are Low: People Who Menstruate Deserve Gender-Specific Cancer Care', JNCCN Journal of the National Comprehensive Cancer Network, 21, pp. 366 - 372, http://dx.doi.org/10.6004/jnccn.2022.7255

Bryant C; Abadir E; Doo NW; Bryant A; McCaughan G; Yang S; Vanguru V; King T; Joshua D; Ho PJ, 2023, 'P-070 Failure to clear circulating tumor cells after one week of daratumumab, bortezomib and dexamethasone is associated with a reduced progression-free survival for myeloma patients', Clinical Lymphoma Myeloma and Leukemia, 23, pp. S73 - S73, http://dx.doi.org/10.1016/s2152-2650(23)01688-9

Moore E; Harrison S; Ho PJ; Irving A; King T; McCaughan G; McQuilten Z; Mollee P; Park S; Petrie D; Reynolds J; Rutherford C; van Tonder T; Wellard C; Wood E; Spencer A, 2023, 'P-476 More efficient delivery of high-cost standard-of-care therapies in relapsed multiple myeloma using real-time feedback of patient-reported outcome measures: the MY-PROMPT-2 trial', Clinical Lymphoma Myeloma and Leukemia, 23, pp. S301 - S302, http://dx.doi.org/10.1016/s2152-2650(23)02093-1

McCaughan GJ; Gandolfi S; Moore JJ; Richardson PG, 2022, 'Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review', British Journal of Haematology, 199, pp. 190 - 204, http://dx.doi.org/10.1111/bjh.18295

Jiang W; Clancy LE; Avdic S; Sutrave G; Street J; Simms R; McGuire HM; Patrick E; Chan AS; McCaughan G; Myers N; Micklethwaite KP; Antonenas V; Selim AG; Ritchie D; Bateman CM; Shaw PJ; Blyth E; Gottlieb DJ, 2022, 'Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant', Blood Advances, 6, pp. 4949 - 4966, http://dx.doi.org/10.1182/bloodadvances.2022007103

Chai KL; Wellard C; Aoki N; Moore EM; Augustson B; Bapat A; Blacklock HA; Chng WJ; Cooke R; Forsyth C; Hamad N; Harrison SJ; Ho PJ; Hocking J; Kerridge IH; Kim JS; Kim K; King T; McCaughan GJ; Mollee P; Morrissey CO; Murphy N; Quach H; Tan XN; Tso A; Wong K; Spencer A; Wood EM; McQuilten ZK, 2022, 'P1573: VARIATION IN USE OF IMMUNOGLOBULIN AND IMPACT ON SURVIVAL IN MULTIPLE MYELOMA: A REPORT FROM THE AUSTRALIA/NEW ZEALAND (ANZ) AND ASIA-PACIFIC (APAC) MYELOMA AND RELATED DISEASES REGISTRIES (MRDR)', HemaSphere, 6, pp. 1454 - 1455, http://dx.doi.org/10.1097/01.hs9.0000849148.93868.54

Lasica M; Spencer A; Campbell P; Wallington-Gates C; Wong Doo N; Janowski W; McCaughan G; Puliyayil A; Yuen F; Le K; Reynolds J; Quach H, 2022, 'P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY.', HemaSphere, 6, pp. 836 - 837, http://dx.doi.org/10.1097/01.hs9.0000846652.51254.ac

Withers B; McCaughan G; Hayward C; Kotlyar E; Jabbour A; Rainer S; De Angelis E; Horvath N; Milliken S; Dogan A; MacDonald P; Moore J, 2022, 'Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort', Internal Medicine Journal, 52, pp. 69 - 78, http://dx.doi.org/10.1111/imj.15072

Lasica M; Spencer A; Campbell P; Wallington-Gates C; Doo NW; Janowski W; McCaughan G; Puliyayil A; Yuen F; Le K; Reynolds J; Quach H, 2022, 'OAB-048: An interim analysis of a phase I/II single arm study of belantamab mafodotin, carfilzomib and dexamethasone in patients with relapsed multiple myeloma: AMaRC 19-02 BelaCarD study', Clinical Lymphoma Myeloma and Leukemia, 22, pp. S29 - S30, http://dx.doi.org/10.1016/s2152-2650(22)00321-4

Chadwick VL; Mills G; Di Ciaccio PR; Tang C; Dear R; Moore J; Milliken S; Withers B; Lavee O; McCaughan GJ; Perram J; Hamad N, 2021, 'A Minority of Women of Child Bearing Potential Are Tested for Pregnancy before Chemoimmunotherapy: An Australian Cancer Centre Experience', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-154028

Mills G; Tang C; Di Ciaccio PR; Chadwick VL; Withers B; Lavee O; Milliken S; Perram J; McCaughan GJ; Hamad N, 2021, 'Systematic Omission of Pregnant and Lactating Women from Malignant Haematology Trials Perpetuates a Cycle of Exclusion, Data Shortage and Disadvantage', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-149354

Chai KL; Wellard C; Moore EM; Augustson B; Bapat A; Blacklock HA; Cooke RE; Forsyth C; Hamad N; Harrison SJ; Ho PJ; Hocking J; Kerridge IH; King T; McCaughan GJ; Mollee P; Morrissey O; Murphy NE; Quach H; Tan XN; Wong K; Spencer A; Wood EM; McQuilten Z, 2021, 'Variation in Use of Immunoglobulin and Impact on Survival in Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)', Blood, 138, pp. 4757 - 4757, http://dx.doi.org/10.1182/blood-2021-147622

Bishop DC; Clancy LE; Simms R; Burgess J; Mathew G; Moezzi L; Street JA; Sutrave G; Atkins E; McGuire HM; Gloss BS; Lee K; Jiang W; Maddock K; McCaughan G; Avdic S; Antonenas V; O'Brien TA; Shaw PJ; Irving DO; Gottlieb DJ; Blyth E; Micklethwaite KP, 2021, 'Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells', Blood, 138, pp. 1504 - 1509, http://dx.doi.org/10.1182/blood.2021010813

McCaughan G; Jarvis S; Joseph J, 2021, 'Abnormal coagulation profiles in monoclonal gammopathy of undetermined significance: a case series', Pathology, 53, pp. 798 - 800, http://dx.doi.org/10.1016/j.pathol.2020.11.005

Hung D; Lenton D; Eslick R; Blennerhassett R; Joshi M; McCaughan G; Day S; Wright D, 2021, 'Chromosome microarray characterisation of chromosome arm 12p loss associated with complex molecular karyotype and recurrent adverse cytogenetic markers in multiple myeloma', Genes Chromosomes and Cancer, 60, pp. 668 - 677, http://dx.doi.org/10.1002/gcc.22975

McCaughan G; Di Ciaccio P; Ananda-Rajah M; Gilroy N; MacIntyre R; Teh B; Weinkove R; Curnow J; Szer J; Enjeti AK; Ross DM; Mulligan S; Trotman J; Dickinson M; Quach H; Choi P; Polizzotto MN; Tam CS; Ho PJ; Ku M; Gregory G; Gangatharan S; Hapgood G; Cochrane T; Cheah C; Gibbs S; Wei A; Johnston A; Greenwood M; Prince HM; Latimer M; Berkahn L; Wight J; Armytage T; Hamad N, 2021, 'COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement', Internal Medicine Journal, 51, pp. 763 - 768, http://dx.doi.org/10.1111/imj.15247

McCaughan GJ; Verma A; Ling S; Lavee O; Moore JJ; Bryant A, 2021, 'Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres', Bone Marrow Transplantation, 56, pp. 738 - 740, http://dx.doi.org/10.1038/s41409-020-01086-9

McCaughan G; Ma D; Moore J, 2021, 'Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia', Bone Marrow Transplantation, 56, pp. 514 - 516, http://dx.doi.org/10.1038/s41409-020-01025-8

McCaughan GJ; Tran S; Durrant S; Harrison S; Morton J; Horvath N; Spencer A; Kerridge IH; Ke Er JA; Barge L; Bryant A; Filshie R; Choong E; Lai HC; Tiley C; Mills A; Butler A; Moore J; Hertzberg M; Kennedy G; Ho PJ; Sidiqi MH; Bashford J; Routledge D; Taylor K; Lee C; Kalff A; Xia W; Hamad N, 2021, 'Trends and Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, 27, pp. S399 - S401, http://dx.doi.org/10.1016/s2666-6367(21)00515-7

McCaughan GJ; Crowther HJ; Chen V; Chunilal SD; Merriman E; Bortz H; Young L; Tran HA; Yuen HLA; Curnow J, 2020, 'Australian and New Zealand Registry of Anticoagulation in the Obese: Prescribing Patterns, Drug Levels and Patient Outcomes', Blood, 136, pp. 21 - 21, http://dx.doi.org/10.1182/blood-2020-143150

McCaughan GJ; Tran S; Durrant S; Harrison SJ; Morton J; Horvath N; Spencer A; Kerridge IH; Er JAK; Barge L; Bryant A; Filshie RJ; Choong E; Lai HC; Tiley C; Mills AK; Butler A; Moore J; Hertzberg M; Kennedy GA; Ho PJ; Sidiqi MH; Bashford J; Routledge D; Taylor K; Lee CH; Kalff A; Xia W; Hamad N, 2020, 'Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', Blood, 136, pp. 11 - 12, http://dx.doi.org/10.1182/blood-2020-138991

McCaughan GJ; Verma A; Ling S; Lavee O; Moore J; Bryant A, 2020, 'Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres', Blood, 136, pp. 42 - 43, http://dx.doi.org/10.1182/blood-2020-139269

Di Ciaccio P; McCaughan G; Trotman J; Ho PJ; Cheah CY; Gangatharan S; Wight J; Ku M; Quach H; Gasiorowski R; Polizzotto MN; Prince HM; Mulligan S; Tam CS; Gregory G; Hapgood G; Spencer A; Dickinson M; Latimer M; Johnston A; Armytage T; Lee C; Cochrane T; Berkhahn L; Weinkove R; Doocey R; Harrison SJ; Webber N; Lee HP; Chapman S; Campbell BA; Gibbs SDJ; Hamad N, 2020, 'Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic', Internal Medicine Journal, 50, pp. 667 - 679, http://dx.doi.org/10.1111/imj.14859

Blennerhassett R; McCaughan G; Tegg E, 2019, 'Massive Splenomegaly, An Unexpected Diagnosis', Pathology, 51, pp. S41 - S41, http://dx.doi.org/10.1016/j.pathol.2018.12.091

Blennerhassett R; McCaughan G; Tegg E, 2018, 'An unexpected diagnosis: leukaemic presentation of blastic plasmacytoid dendritic cell neoplasm with massive splenomegaly', Pathology, 50, pp. 773 - 775, http://dx.doi.org/10.1016/j.pathol.2018.05.007

McCaughan GJB; Favaloro EJ; Pasalic L; Curnow J, 2018, 'Anticoagulation at the extremes of body weight: choices and dosing', Expert Review of Hematology, 11, pp. 817 - 828, http://dx.doi.org/10.1080/17474086.2018.1517040

Favaloro EJ; McCaughan G; Mohammed S; Lau KKE; Gemmell R; Cavanaugh L; Donikian D; Kondo M; Brighton T; Pasalic L, 2018, 'HIT or miss? A comprehensive contemporary investigation of laboratory tests for heparin induced thrombocytopenia', Pathology, 50, pp. 426 - 436, http://dx.doi.org/10.1016/j.pathol.2017.11.089

Favaloro EJ; McCaughan GJB; Mohammed S; Pasalic L, 2018, 'Anticoagulation therapy in Australia', Annals of Blood, 3, pp. 48 - 48, http://dx.doi.org/10.21037/aob.2018.12.02

Favaloro EJ; McCaughan G; Pasalic L, 2017, 'Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update', Pathology, 49, pp. 346 - 355, http://dx.doi.org/10.1016/j.pathol.2017.02.005

McCaughan G; Massey J; Sutton I; Curnow J, 2017, 'Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis', BMJ Case Reports, 2017, http://dx.doi.org/10.1136/bcr-2017-223016

McCaughan GJB; Fulham MJ; Mahar A; Soper J; Hong AM; Stalley PD; Tattersall MHN; Bhadri VA, 2016, 'Programmed cell death-1 blockade in recurrent disseminated Ewing sarcoma', Journal of Hematology and Oncology, 9, http://dx.doi.org/10.1186/s13045-016-0278-x

Mccaughan GJ; Blinman PL; Boyer MJ; Stockler MR, 2013, 'Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer', Internal Medicine Journal, 43, pp. 424 - 429, http://dx.doi.org/10.1111/j.1445-5994.2012.02846.x

Kiely BE; McCaughan G; Christodoulou S; Beale PJ; Grimison P; Trotman J; Tattersall MHN; Stockler MR, 2013, 'Using scenarios to explain life expectancy in advanced cancer: Attitudes of people with a cancer experience', Supportive Care in Cancer, 21, pp. 369 - 376, http://dx.doi.org/10.1007/s00520-012-1526-4

Stockler MR; Kiely BE; McCaughan GJ; Christodoulou S; Beale PJ; Trotman J; Grimison P; Tattersall MHN, 2012, 'Using scenarios to explain survival time: Attitudes of people with a cancer experience.', Journal of Clinical Oncology, 30, pp. 9126 - 9126, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9126

Back to profile page